aTENSION.life raises USD 3M in seed funding led by Wlanholding to develop precision diagnostics for hypertension.

May 08, 2025•8 months ago

Amount Raised

$3 Million

Round Type

seed

ViennaHealth DiagnosticsBiotechnologyHealth Care

Investors

Vp Venture PartnersE QventureWlanholding

Description

aTENSION.life, a Vienna-based startup, raised USD 3M in seed financing for its advanced mass spectrometry-based diagnostics. The funding round was led by Wlanholding, with participation from eQventure and VP Venture Partners. Dr. Werner Lanthaler has been appointed Chairman of the Supervisory Board

Company Information

Company

aTENSION.life

Location

Vienna, Vienna, Austria

About

At aTENSION, we are redefining the future of hypertension care. It is our mission to make advanced mass spectrometry diagnostics accessible to everyone. Our ALDO+ testing platform sets new standards in precision diagnosis and personalized treatments enhancing the well-being and life quality of hypertensive patients. With just one blood sample it identifies underlying causes of uncontrolled hypertension and personalizes treatment therapies. ALDO+ is transforming hypertension diagnostics with unparalleled benefits for clinicians, labs and patients, delivering high diagnostic value, operational simplicity and cost efficacy.

Related People

3 contacts

Funding Insights

Based on industry data

VC-backed spending patterns